Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2019. Start Trial.
Date Value
November 20, 2026 0.7112
November 19, 2026 0.7674
November 18, 2026 0.8016
November 17, 2026 0.775
November 16, 2026 0.8434
November 13, 2026 0.9725
November 12, 2026 1.010
November 11, 2026 1.102
November 10, 2026 1.102
November 09, 2026 1.140
November 06, 2026 0.9877
November 05, 2026 0.9725
November 04, 2026 1.079
November 03, 2026 1.079
November 02, 2026 1.086
October 30, 2026 1.147
October 29, 2026 1.204
October 28, 2026 1.155
October 27, 2026 1.106
October 26, 2026 1.026
October 23, 2026 1.117
October 22, 2026 1.155
October 21, 2026 1.170
October 20, 2026 1.223
October 19, 2026 1.124
Date Value
October 16, 2026 1.071
October 15, 2026 1.178
October 14, 2026 1.231
October 13, 2026 1.284
October 12, 2026 1.36
October 09, 2026 1.466
October 08, 2026 1.482
October 07, 2026 1.497
October 06, 2026 1.535
October 05, 2026 1.580
October 02, 2026 1.520
October 01, 2026 1.436
September 30, 2026 1.459
September 29, 2026 1.577
September 28, 2026 1.593
September 25, 2026 1.649
September 24, 2026 1.716
September 23, 2026 1.768
September 22, 2026 1.991
September 21, 2026 1.959
September 18, 2026 2.031
September 17, 2026 2.055
September 16, 2026 1.983
September 15, 2026 2.067
September 14, 2026 2.318

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Agenus, Inc. --
Amgen, Inc. 16.42
Anika Therapeutics, Inc. 1.288
BioCryst Pharmaceuticals, Inc. --
Imunon, Inc. 1.268

Price to Book Value Related Metrics

Price 0.9361
Earnings Yield -152.5%
Market Cap 201.94M